Published in Hum Genet on March 01, 1998
The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol (2001) 2.83
Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol (2002) 1.47
Genetic advances in sarcomeric cardiomyopathies: state of the art. Cardiovasc Res (2015) 1.19
Contemporary treatment of hypertrophic cardiomyopathy. Tex Heart Inst J (2009) 1.12
Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Minerva Med (2001) 1.00
Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet (1999) 0.95
Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy. Circ Cardiovasc Genet (2011) 0.93
On predictors of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol (2003) 0.83
Hypertrophic cardiomyopathy: how do mutations lead to disease? Arq Bras Cardiol (2014) 0.78
Genetic counselling for hypertrophic cardiomyopathy: are we ready for it? Curr Control Trials Cardiovasc Med (2000) 0.75
A One Health Approach to Hypertrophic Cardiomyopathy. Yale J Biol Med (2017) 0.75
Action of nicking-closing enzyme on supercoiled and nonsupercoiled closed circular DNA: formation of a Boltzmann distribution of topological isomers. Proc Natl Acad Sci U S A (1975) 6.26
Incorporation of phosphorothioate groups into fd and phi X174 DNA. Biochemistry (1977) 6.10
A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell (1990) 5.77
DNA synthesis in nucleotide-permeable Escherichia coli cells. I. Preparation and properties of ether-treated cells. J Mol Biol (1971) 4.65
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell (1994) 4.47
Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92
Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet (2000) 3.87
The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab (2001) 3.55
A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet (1996) 3.31
DNA topoisomerases: enzymes that control DNA conformation. Curr Top Microbiol Immunol (1985) 3.10
Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet (1998) 3.08
Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82
Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet (1998) 2.79
Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.52
An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet (1998) 2.48
MITOP, the mitochondrial proteome database: 2000 update. Nucleic Acids Res (2000) 2.43
Direct sequencing of polymerase chain reaction amplified DNA fragments through the incorporation of deoxynucleoside alpha-thiotriphosphates. Nucleic Acids Res (1988) 2.28
Isolation and partial characterisation of the relaxation protein from nuclei of cultured mouse and human cells. Eur J Biochem (1975) 2.27
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene. Cell (1990) 1.92
A new family of interspersed repetitive DNA sequences in the mouse genome. J Mol Biol (1982) 1.90
Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol (1993) 1.81
MitoP2: the mitochondrial proteome database--now including mouse data. Nucleic Acids Res (2006) 1.79
Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet (1997) 1.69
The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. Genomics (1990) 1.67
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet (1997) 1.64
Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Ann Neurol (1999) 1.63
Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med (1992) 1.58
MitoP2, an integrated database on mitochondrial proteins in yeast and man. Nucleic Acids Res (2004) 1.55
MITOP: database for mitochondria-related proteins, genes and diseases. Nucleic Acids Res (1999) 1.49
S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma. J Clin Oncol (1999) 1.49
Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1. J Biochem Biophys Methods (1990) 1.46
The retinitis pigmentosa GTPase regulator, RPGR, interacts with the delta subunit of rod cyclic GMP phosphodiesterase. Proc Natl Acad Sci U S A (1999) 1.46
Purification and demonstration of the enzymatic character of the nicking-closing protein from mouse L cells. Biochem Biophys Res Commun (1976) 1.35
Enzymatic amplification of myosin heavy-chain mRNA sequences in vitro. DNA (1988) 1.34
The mitochondrial proteome database: MitoP2. Methods Enzymol (2009) 1.33
DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods (2001) 1.30
Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Chromosoma (1986) 1.30
Analysis of covalent complexes formed between calf thymus DNA topoisomerase and single-stranded DNA. Eur J Biochem (1980) 1.30
A K(ATP) channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila. Mol Psychiatry (2011) 1.30
A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation (2000) 1.26
Partial characterization of the human beta-myosin heavy-chain gene which is expressed in heart and skeletal muscle. Eur J Biochem (1986) 1.24
Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet (1992) 1.22
A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet (1996) 1.21
Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2). Dev Dyn (1998) 1.21
Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing. Leukemia (2011) 1.20
Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res (1997) 1.19
Relaxation of supercoiled phosphorothioate DNA by mammalian topoisomerases is inhibited in a base-specific manner. J Biol Chem (1985) 1.18
Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families. Circ Res (1992) 1.16
A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436, and CRI-L329 on chromosome 14 at q11-q12. Am J Hum Genet (1990) 1.14
Features of mtDNA mutation patterns in European pedigrees and sporadic cases with Leber hereditary optic neuropathy. Am J Hum Genet (1994) 1.14
Leber's hereditary optic neuroretinopathy and the X-chromosomal susceptibility factor: no linkage to DXs7. Hum Hered (1992) 1.13
Mutations in the candidate gene for Norrie disease. Hum Mol Genet (1992) 1.13
Effect of deoxynucleoside phosphorothioates incorporated in DNA on cleavage by restriction enzymes. J Biol Chem (1982) 1.12
DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum Genet (1995) 1.11
DNA topoisomerase II cleaves at specific sites in the 5' flanking region of c-fos proto-oncogenes in vitro. EMBO J (1986) 1.11
Replication of restless legs syndrome loci in three European populations. J Med Genet (2009) 1.08
Differences in clinical characteristics and frequency of accompanying migraine features in episodic and chronic cluster headache. Cephalalgia (2012) 1.08
Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations. Neurology (2006) 1.06
A splice site variant in the sodium channel gene SCN1A confers risk of febrile seizures. Neurology (2009) 1.05
Stroke volume and left ventricular output in preterm infants with patent ductus arteriosus. Pediatr Res (1990) 1.04
Acute inferior cardiac inflow obstruction resulting from inadvertent surgical closure of a prominent Eustachian valve mistaken for an atrial septal defect. Pediatr Cardiol (1999) 1.03
An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the DiGeorge syndrome region on 10p13/14. J Med Genet (2000) 1.03
A systematic mutation screen of 10 nuclear and 25 mitochondrial candidate genes in 21 patients with cytochrome c oxidase (COX) deficiency shows tRNA(Ser)(UCN) mutations in a subgroup with syndromal encephalopathy. J Med Genet (1998) 1.03
Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. Hum Genet (2001) 1.03
Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol Genet Metab (2001) 1.02
Heart rate and systolic time intervals in healthy newborn infants: longitudinal study. Pediatr Cardiol (1985) 1.02
Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet (1992) 1.01
Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2). Eur J Hum Genet (1998) 1.00
Evidence for genetic heterogeneity in Best's vitelliform macular dystrophy. J Med Genet (1995) 1.00
A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I. J Med Genet (2000) 1.00
Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol (1997) 0.99
Intraperitoneal application of bupivacaine during laparoscopic cholecystectomy--risk or benefit? Anesth Analg (1995) 0.98
A gene (SRPX) encoding a sushi-repeat-containing protein is deleted in patients with X-linked retinitis pigmentosa. Hum Mol Genet (1995) 0.98
Cloning and gene structure of the rod cGMP phosphodiesterase delta subunit gene (PDED) in man and mouse. Eur J Hum Genet (1998) 0.98
A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis. J Clin Invest (1994) 0.96
Familial mental retardation syndrome ATR-16 due to an inherited cryptic subtelomeric translocation, t(3;16)(q29;p13.3). Am J Hum Genet (2000) 0.95
DiGeorge syndrome and partial monosomy 10p: case report and review. Ann Genet (1995) 0.95
Developmental expression analysis of murine autotaxin (ATX). Mech Dev (1999) 0.94
Adolescent growth: genes, hormones and the peer group. Proceedings of the 20th Aschauer Soiree, held at Glücksburg castle, Germany, 15th to 17th November 2013. Pediatr Endocrinol Rev (2014) 0.93
Inhibition of calf thymus type II DNA topoisomerase by poly(ADP-ribosylation). EMBO J (1985) 0.92
DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP-ribosylation). Eur J Biochem (1983) 0.92
Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products. Hum Mol Genet (1998) 0.91
Infantile neuroaxonal dystrophy and pantothenate-kinase-associated neurodegeneration: locus heterogeneity. Neurology (2004) 0.91
Chromosomal localization of a human myosin heavy-chain gene by in situ hybridization. Hum Genet (1983) 0.91
HLA antigens in children with idiopathic nephrotic syndrome. Proc Eur Dial Transplant Assoc (1980) 0.90
Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circ Res (1990) 0.90
Molecular cloning of DNA. An introduction into techniques and problems. Hum Genet (1977) 0.90
Transcriptional and translational control of glucose-stimulated (pro)insulin biosynthesis. Eur J Biochem (1980) 0.89
Long-range map of a 3.5-Mb region in Xp11.23-22 with a sequence-ready map from a 1.1-Mb gene-rich interval. Genome Res (1996) 0.89
Crystallization and preliminary X-ray diffraction studies of a bacterial flavohemoglobin protein. Proteins (1995) 0.89
Expression and mutation analysis of BRUNOL3, a candidate gene for heart and thymus developmental defects associated with partial monosomy 10p. J Mol Med (Berl) (2002) 0.88
Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family. Hum Genet (2000) 0.88
Report of the third international workshop on human chromosome 10 mapping and sequencing 1999. Cytogenet Cell Genet (2000) 0.88
Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene. Hum Mol Genet (1998) 0.88